【表紙】
|
【提出書類】
|
四半期報告書
|
|
【根拠条文】
|
金融商品取引法第24条の４の７第１項
|
|
【提出先】
|
関東財務局長
|
|
【提出日】
|
2024年２月９日
|
|
【四半期会計期間】
|
第24期第３四半期（自 2023年10月１日 至 2023年12月31日）
|
|
【会社名】
|
エムスリー株式会社
|
|
【英訳名】
|
M3, Inc.
|
|
【代表者の役職氏名】
|
代表取締役社長 谷 村 格
|
|
【本店の所在の場所】
|
東京都港区赤坂一丁目11番44号
|
|
【電話番号】
|
03（6229）8900（代表）
|
|
【事務連絡者氏名】
|
執行役員 大 場 啓 史
|
|
【最寄りの連絡場所】
|
東京都港区赤坂一丁目11番44号
|
|
【電話番号】
|
03（6229）8900（代表）
|
|
【事務連絡者氏名】
|
執行役員 大 場 啓 史
|
|
【縦覧に供する場所】
|
株式会社東京証券取引所
（東京都中央区日本橋兜町２番１号）
|
E05425
24130
エムスリー株式会社
M3, Inc.
企業内容等の開示に関する内閣府令
第四号の三様式
IFRS
true
CTE
2023-04-01
2023-12-31
Q3
2024-03-31
2022-04-01
2022-12-31
2023-03-31
1
false
false
false
E05425-000
2023-04-01
2023-12-31
jpcrp040300-q3r_E05425-000:SiteSolutionReportableSegmentMember
E05425-000
2022-04-01
2022-12-31
jpcrp040300-q3r_E05425-000:SiteSolutionReportableSegmentMember
E05425-000
2022-04-01
2022-12-31
jpcrp040300-q3r_E05425-000:OtherEmergingBusinessMember
E05425-000
2022-04-01
2022-12-31
jpcrp_cor:ReportableSegmentsMember
E05425-000
2022-04-01
2022-12-31
jpcrp040300-q3r_E05425-000:OverseasReportableSegmentMember
E05425-000
2022-04-01
2022-12-31
jpcrp040300-q3r_E05425-000:CareerSolutionReportableSegmentMember
E05425-000
2022-04-01
2022-12-31
jpcrp040300-q3r_E05425-000:EvidenceSolutionReportableSegmentMember
E05425-000
2022-04-01
2022-12-31
jpcrp040300-q3r_E05425-000:MedicalPlatformReportableSegmentMember
E05425-000
2023-04-01
2023-12-31
jpcrp_cor:ReconcilingItemsMember
E05425-000
2023-04-01
2023-12-31
jpcrp040300-q3r_E05425-000:OtherEmergingBusinessMember
E05425-000
2023-04-01
2023-12-31
jpcrp_cor:ReportableSegmentsMember
E05425-000
2023-04-01
2023-12-31
jpcrp040300-q3r_E05425-000:OverseasReportableSegmentMember
E05425-000
2023-04-01
2023-12-31
jpcrp040300-q3r_E05425-000:CareerSolutionReportableSegmentMember
E05425-000
2023-04-01
2023-12-31
jpcrp040300-q3r_E05425-000:EvidenceSolutionReportableSegmentMember
E05425-000
2023-04-01
2023-12-31
jpcrp040300-q3r_E05425-000:MedicalPlatformReportableSegmentMember
E05425-000
2022-04-01
2022-12-31
jpcrp_cor:ReconcilingItemsMember
E05425-000
2023-12-31
jpigp_cor:NonControllingInterestsIFRSMember
E05425-000
2023-12-31
jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember
E05425-000
2023-12-31
jpigp_cor:RetainedEarningsIFRSMember
E05425-000
2023-12-31
jpigp_cor:OtherComponentsOfEquityIFRSMember
E05425-000
2023-12-31
jpigp_cor:TreasurySharesIFRSMember
E05425-000
2023-12-31
jpigp_cor:CapitalSurplusIFRSMember
E05425-000
2023-12-31
jpigp_cor:ShareCapitalIFRSMember
E05425-000
2023-04-01
2023-12-31
jpigp_cor:NonControllingInterestsIFRSMember
E05425-000
2023-04-01
2023-12-31
jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember
E05425-000
2023-04-01
2023-12-31
jpigp_cor:RetainedEarningsIFRSMember
E05425-000
2023-04-01
2023-12-31
jpigp_cor:OtherComponentsOfEquityIFRSMember
E05425-000
2023-04-01
2023-12-31
jpigp_cor:TreasurySharesIFRSMember
E05425-000
2023-04-01
2023-12-31
jpigp_cor:CapitalSurplusIFRSMember
E05425-000
2023-04-01
2023-12-31
jpigp_cor:ShareCapitalIFRSMember
E05425-000
2023-03-31
jpigp_cor:NonControllingInterestsIFRSMember
E05425-000
2023-03-31
jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember
E05425-000
2023-03-31
jpigp_cor:RetainedEarningsIFRSMember
E05425-000
2023-03-31
jpigp_cor:OtherComponentsOfEquityIFRSMember
E05425-000
2023-03-31
jpigp_cor:TreasurySharesIFRSMember
E05425-000
2023-03-31
jpigp_cor:CapitalSurplusIFRSMember
E05425-000
2023-03-31
jpigp_cor:ShareCapitalIFRSMember
E05425-000
2022-12-31
jpigp_cor:NonControllingInterestsIFRSMember
E05425-000
2022-12-31
jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember
E05425-000
2022-12-31
jpigp_cor:RetainedEarningsIFRSMember
E05425-000
2022-12-31
jpigp_cor:OtherComponentsOfEquityIFRSMember
E05425-000
2022-12-31
jpigp_cor:TreasurySharesIFRSMember
E05425-000
2022-12-31
jpigp_cor:CapitalSurplusIFRSMember
E05425-000
2022-12-31
jpigp_cor:ShareCapitalIFRSMember
E05425-000
2022-04-01
2022-12-31
jpigp_cor:NonControllingInterestsIFRSMember
E05425-000
2022-04-01
2022-12-31
jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember
E05425-000
2022-04-01
2022-12-31
jpigp_cor:RetainedEarningsIFRSMember
E05425-000
2022-04-01
2022-12-31
jpigp_cor:OtherComponentsOfEquityIFRSMember
E05425-000
2022-04-01
2022-12-31
jpigp_cor:TreasurySharesIFRSMember
E05425-000
2022-04-01
2022-12-31
jpigp_cor:CapitalSurplusIFRSMember
E05425-000
2022-04-01
2022-12-31
jpigp_cor:ShareCapitalIFRSMember
E05425-000
2022-03-31
jpigp_cor:NonControllingInterestsIFRSMember
E05425-000
2022-03-31
jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember
E05425-000
2022-03-31
jpigp_cor:RetainedEarningsIFRSMember
E05425-000
2022-03-31
jpigp_cor:OtherComponentsOfEquityIFRSMember
E05425-000
2022-03-31
jpigp_cor:TreasurySharesIFRSMember
E05425-000
2022-03-31
jpigp_cor:CapitalSurplusIFRSMember
E05425-000
2022-03-31
jpigp_cor:ShareCapitalIFRSMember
E05425-000
2024-02-09
jpcrp_cor:OrdinaryShareMember
E05425-000
2023-12-31
jpcrp_cor:SharesWithNoVotingRightsMember
E05425-000
2023-12-31
jpcrp_cor:SharesWithRestrictedVotingRightsTreasurySharesEtcMember
E05425-000
2023-12-31
jpcrp_cor:SharesWithRestrictedVotingRightsOtherMember
E05425-000
2023-12-31
jpcrp_cor:SharesWithFullVotingRightsTreasurySharesEtcMember
E05425-000
2023-12-31
jpcrp_cor:OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember
E05425-000
2023-12-31
jpcrp_cor:SharesWithFullVotingRightsOtherMember
E05425-000
2023-12-31
jpcrp_cor:OrdinarySharesSharesWithFullVotingRightsOtherMember
E05425-000
2023-12-31
jpcrp_cor:SharesLessThanOneUnitMember
E05425-000
2023-12-31
jpcrp_cor:OrdinarySharesSharesLessThanOneUnitMember
E05425-000
2023-12-31
jpcrp_cor:Row1Member
E05425-000
2024-02-09
E05425-000
2023-12-31
E05425-000
2023-04-01
2023-12-31
E05425-000
2022-12-31
E05425-000
2022-04-01
2022-12-31
E05425-000
2023-03-31
E05425-000
2022-04-01
2023-03-31
E05425-000
2022-03-31
E05425-000
2023-10-01
2023-12-31
E05425-000
2022-10-01
2022-12-31
E05425-000
2022-10-01
2022-12-31
jpcrp_cor:ReportableSegmentsMember
E05425-000
2022-10-01
2022-12-31
jpcrp040300-q3r_E05425-000:MedicalPlatformReportableSegmentMember
E05425-000
2022-10-01
2022-12-31
jpcrp040300-q3r_E05425-000:EvidenceSolutionReportableSegmentMember
E05425-000
2022-10-01
2022-12-31
jpcrp040300-q3r_E05425-000:CareerSolutionReportableSegmentMember
E05425-000
2022-10-01
2022-12-31
jpcrp040300-q3r_E05425-000:SiteSolutionReportableSegmentMember
E05425-000
2022-10-01
2022-12-31
jpcrp040300-q3r_E05425-000:OverseasReportableSegmentMember
E05425-000
2022-10-01
2022-12-31
jpcrp040300-q3r_E05425-000:OtherEmergingBusinessMember
E05425-000
2022-10-01
2022-12-31
jpcrp_cor:ReconcilingItemsMember
E05425-000
2023-10-01
2023-12-31
jpcrp_cor:ReportableSegmentsMember
E05425-000
2023-10-01
2023-12-31
jpcrp040300-q3r_E05425-000:MedicalPlatformReportableSegmentMember
E05425-000
2023-10-01
2023-12-31
jpcrp040300-q3r_E05425-000:EvidenceSolutionReportableSegmentMember
E05425-000
2023-10-01
2023-12-31
jpcrp040300-q3r_E05425-000:CareerSolutionReportableSegmentMember
E05425-000
2023-10-01
2023-12-31
jpcrp040300-q3r_E05425-000:SiteSolutionReportableSegmentMember
E05425-000
2023-10-01
2023-12-31
jpcrp040300-q3r_E05425-000:OverseasReportableSegmentMember
E05425-000
2023-10-01
2023-12-31
jpcrp040300-q3r_E05425-000:OtherEmergingBusinessMember
E05425-000
2023-10-01
2023-12-31
jpcrp_cor:ReconcilingItemsMember
iso4217:JPY
xbrli:shares
iso4217:JPY
xbrli:shares
xbrli:pure